We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALA
4551
DELISTED
Calithera Biosciences, Inc
CALA
$113K ﹤0.01%
2,597
-350
-12% -$15.1K
VPCBW
4552
DELISTED
VPC Impact Acquisition Holdings II Warrant
VPCBW
$112K ﹤0.01%
93,494
+76,828
+461% +$90K
OPALW
4553
DELISTED
OPAL Fuels Inc. Warrant
OPALW
$112K ﹤0.01%
106,428
+40,000
+60% +$48.3K
WPCB.WS
4554
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$112K ﹤0.01%
120,750
+54,084
+81% +$63.5K
KIIIW
4555
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$112K ﹤0.01%
214,049
+172,383
+414% +$123K
SB icon
4556
Safe Bulkers
SB
$781M
$110K ﹤0.01%
21,233
-68,990
-76% -$266K
ASPS icon
4557
Altisource Portfolio Solutions
ASPS
$65.4M
$109K ﹤0.01%
1,377
-6,432
-82% -$479K
IPOD.WS
4558
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$109K ﹤0.01%
62,500
STGW icon
4559
Stagwell
STGW
$1.84B
$107K ﹤0.01%
+13,959
New +$93.1K
HIIIW
4560
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$107K ﹤0.01%
124,886
+84,886
+212% +$86.4K
ATIP.WS
4561
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$105K ﹤0.01%
159,560
CLRM
4562
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
$105K ﹤0.01%
+10,672
New +$103K
ELOX
4563
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$104K ﹤0.01%
+1,592
New +$98.2K
QTT
4564
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$102K ﹤0.01%
10,293
-35,728
-78% -$513K
CLAA.WS
4565
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$101K ﹤0.01%
124,734
+88,879
+248% +$83.9K
ONCT
4566
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$100K ﹤0.01%
+1,198
New +$99.1K
HYLN icon
4567
PUT
Hyliion Holdings
HYLN
$663M
$99K ﹤0.01%
+11,800
New +$109K
TWNT.WS
4568
DELISTED
Tailwind Two Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant
TWNT.WS
$99K ﹤0.01%
100,079
+66,601
+199% +$59.3K
JWSM.WS
4569
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$97K ﹤0.01%
84,528
+34,528
+69% +$39.8K
AMRX icon
4570
Amneal Pharmaceuticals
AMRX
$5.72B
$96K ﹤0.01%
+18,042
New +$90.8K
HOOK
4571
DELISTED
HOOKIPA Pharma
HOOK
$96K ﹤0.01%
1,625
-44
-3% -$3.19K
IPVF.WS
4572
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$96K ﹤0.01%
74,952
+51,619
+221% +$56.9K
BTMDW
4573
DELISTED
Biote Corp. Warrant
BTMDW
$94K ﹤0.01%
+116,961
New +$104K
DILAW
4574
DELISTED
DILA Capital Acquisition Corp. Warrant
DILAW
$94K ﹤0.01%
+151,000
New +$95.1K
EQD.WS
4575
DELISTED
Equity Distribution Acquisition Corp. Warrants, each whole warrant exercisable for one share of Clas
EQD.WS
$94K ﹤0.01%
104,166

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.